What Researchers Did
Researchers conducted a prospective randomized controlled trial involving 60 soldiers with idiopathic sudden sensorineural hearing loss to compare hearing recovery outcomes between those receiving conventional treatment alone versus conventional treatment plus hyperbaric oxygen therapy.
What They Found
Of the 60 participants (53 male, 7 female), no significant differences were observed in baseline characteristics between the two groups. While hearing recovery on days 8 and 13 showed no significant differences, the group receiving conventional treatment plus hyperbaric oxygen therapy demonstrated significantly better hearing recovery on day 180 (P<0.05), with no significant side effects reported in either group.
What This Means for Canadian Patients
For Canadian patients diagnosed with idiopathic sudden sensorineural hearing loss, these findings suggest that adding hyperbaric oxygen therapy to conventional treatment could lead to improved long-term hearing recovery. Patients should discuss this potential adjunctive therapy with their healthcare providers to explore its suitability for their individual circumstances.
Canadian Relevance
This study was conducted outside of Canada and does not have a direct Canadian connection.
Study Limitations
A limitation of this study is its focus on a specific population of soldiers, which may limit the generalizability of the findings to the broader civilian population.